A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how it’s delivered—injecting it directly into tumors instead of into the bloodstream. In a small clinical trial of 12 patients with metastatic cancers, six saw their tumors shrink and two experienced complete remission.
source https://www.sciencedaily.com/releases/2026/03/260315225121.htm
"This was not opportunistic. It was precision." — How North Korean hackers
used Microsoft Teams and Slack to compromise Windows PCs with an elaborate
ploy
-
Malware ploys from bad actors are getting more elaborate, as axios
maintainer Jason Saayman explains how the registry's hijacking was weeks in
the making a...
1 hour ago
Welcome to the 'The Fact Factory' friends. Its an interesting Hot Spot which brings to you amazing and little known facts from all over the world. So, sit back, take a tour around the world and enjoy the trivia.
No comments:
Post a Comment